LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,836 pages found matching %3Cscript%3Ealert%28%27What_Security%3F%27%29%3C%2Fscript%3E- Unreasonable Credit Card Rate Hikes
Apr-2-07 San Bernardino, CA: Customers of major credit card companies are becoming increasingly frustrated with unreasonable company practices that result in high fees, rate hikes, and increased debt for the consumer. Now, some people are starting to take action against the credit card companies. Those actions include activities as widespread as a class acti... - Wyeth's Off-Label Promotion of Prempro Leads to 5,200 Lawsuits
Mar-30-07 Washington, DC: For many years, Wyeth led women to believe that taking Prempro , with the combined hormones of estrogen and progestin, would not only relieve hot flashes, vaginal dryness, night sweats, and moodiness, but it would also prevent heart disease, osteoporosis, and mental deterioration. Very little of that advice now appears to be true. The l... - Permax Pulled from the Market
Mar-29-07 Washington, DC: On March 29, 2007, the FDA pulled Permax from the U.S. market due to the risk of heart damage. Marketer Valeant Pharmaceuticals International, has voluntarily stopped sales after news reports that Permax can damage heart valves and cause them to leak. This news worries Beverly J. She took Permax for more than five years and was recently d... - Two Big Settlements In California Overtime Lawsuits
Mar-26-07 Newport Beach, CA: Although overtime lawsuits filed by California police officers have received a lot of attention lately, they are not the only people who have not been properly paid for working overtime hours. Some recently settled lawsuits against a grocery chain and a restaurant company show that many people are at risk for not being properly compens... - Investigators Zero In on Pill Pushing Doctors
Mar-14-07 Washington, DC: The number one goal of drug makers in dispatching sales representatives to meet with doctors face-to-face is to increase sales by convincing doctors to prescribe drugs off-label for unapproved uses, by saying whatever it takes to achieve that goal. A May 2006, study titled, "Turning Medicine Into Snake Oil," analyzed FDA warning letters... - New Orleans Files $77 Billion Lawsuit for Failed Levees
Mar-11-07 New Orleans, LA: The city of New Orleans has filed a $77 billion claim against the United States Army Corps of Engineers seeking compensation for losses incurred after failed levees resulted in flooding of the city. In addition to the city's lawsuit, at least 34,500 other claims had also arrived in the New Orleans district office. In many cases, peop... - J&J's Charite Spinal Disc Bonanza Short Lived
Mar-10-07 Newport, RI The Charite artificial spinal disc was FDA approved in October 2004, as an alternative to spinal fusion surgery. But in reality, experts say, the superiority of the two procedures is limited to the cost. Charite disc replacement can run as high as $50,000, while spinal fusion surgery costs less than half that at roughly $23,000. The Charit... - Makers of Zyprexa Risperdal and Seroquel Under Fire
Mar-9-07 Washington, DC: Eli Lilly, Johnson & Johnson, and AstraZeneca, are all named defendants in a new lawsuit filed by the state of Pennsylvania on February 26, 2007, to recover money paid through public health care programs to purchase Zyprexa , Risperdal, and Seroquel, and the costs of medical care for the people injured by these drugs. Pennsylvania... - FDA - The Rest of the Story
Mar-7-07 Washington, DC: The 12,000-employee FDA regulates products that account for more than $1.5 trillion in yearly sales, or about a 10th of the US economy. Besides food and drug safety, the agency also enforces regulations covering medical devices and cosmetics. The FDA is part of the executive branch of government and therefore, any filing of reports by co... - California Labor Lawsuits
Mar-5-07 Santa Ana, CA: In California, labor lawsuits are being used to help employees receive fair pay when it comes to overtime and off the clock work related activities. Three cases that highlight the issues are the deputies in Santa Ana, the IBM overtime class action suit and the Siebel Systems overtime suit. A federal judge in Santa Ana has given the gr... - Patients require further surgery because of Panacryl Sutures
Mar-1-07 Somerville, NJ Panacryl sutures were recalled last year after it was discovered that they were causing some serious health problems in patients. The recall was announced by the United States Food and Drug Administration (FDA) last year because the organization learned that patient's bodies were rejecting the sutures. Problems associated with the Panac... - Ortho Evra Patch should be Banned
Feb-28-07 Toronto, ON Judy Baker is shocked that the Ortho Evra patch is still available. Baker developed a painful and life-threatening blood clot, and because of her ordeal, she wants to warn women to stay off the patch. "I was on the Ortho Evra patch for about six months, from June to December of 2006," says Baker (not her real name pending a lawsuit). "I wa... - Suicide Risk of Neurontin Kept Hidden for Years
Feb-27-07 Washington, DC: Neurontin , the all-time poster child for an illegally promoted off-label drug, was marketed by Warner-Lambert and its Parke-Davis division until Pfizer acquired the company in 2000. The term "off-label" means prescribing a drug for indications not listed on the label, upping the recommended dose, prescribing a drug in combination with... - Did SSRI Meds cause my Son's Birth Defects?
Feb-26-07 Salt Lake City, UT Trudy Hanson is sitting in a waiting room at Primary Children's Hospital, a room that has become her second home since giving birth to her son - this is Michael's 14th surgery. Trudy says she can't help but blame herself for taking Effexor while she was pregnant. "I started taking Effexor a few months before I was pregnant and cont... - Depakote: A Brief History
Feb-26-07 Portland, OR: Since 1983, Depakote has been marketed in the United States as a medication for the treatment of epilepsy. More than two million Americans have some form of epilepsy, and 125,000 new cases of epilepsy are reported each year. For the drug maker, Abbott Laboratories, sales were brisk, but there were other markets to tap into - also known as "... - Another lawsuit filed against Eli Lilly's Zyprexa
Feb-25-07 Chicago, IL: Eli Lilly faces yet another court appearance to defend its anti-psychotic drug Zyprexa after a lawsuit was filed late last month in Illinois. The plaintiff filed the lawsuit claiming he now suffers from diabetes and permanent bodily and mental harm after taking Zyprexa. He also argues that his illness has caused mental anguish, emotiona... - Panacryl Sutures: Another headache for Ethicon
Feb-24-07 Des Moines, IA The recall of Panacryl Sutures last year, four years after the manufacturer took them off store shelves, is only the latest in a string of headaches for Ethicon, makers of Panacryl. Much like what happened with Ethicon's Vicryl brand of sutures, the company will likely face a string of lawsuits because of problems with the Panacryl Sutures... - More Zyprexa Postcards From the Edge
Feb-18-07 Washington, DC: On February 13, 2007, Judge Jack Weinstein issued a permanent injunction, prohibiting attorney, Jim Gottstein, and Dr David Egilman, an expert witness in litigation involving Zyprexa , from further disseminating certain Eli Lilly documents that were sealed with a court order until Mr Gottstein released them to the media in December 2006... - UnumProvident Tells Customer to Work Despite Internal Bleeding
Feb-17-07 Bethpage, NY: Thomas Villani paid his UnumProvident premiums for years while he worked at Verizon. According to the terms of his policy, in case of illness lasting for more than a year he would receive 65 percent of his income and Verizon would hold his job for another year. Unfortunately, UnumProvident refused to hold up their end of the contract. In... - Trail of Paxil Suicides Leads To GlaxoSmithKline
Feb-14-07 Washington, DC: On January 29, 2007, BBC-One broadcast, "Secrets of the Drug Trials," a Panorama program based on an investigation by reporter, Shelley Jofre, which revealed how GlaxoSmithKline misled doctors into prescribing Paxil off-label to children, even after its own clinical trials found that kids could become suicidal when taking the drug. The...